Showing results (251-260 of 322) with videos related to
Sort By:
Pageof 33
Cancer|July 11, 2023
Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivorsAgnes Dumas, Karen Milcent, Nicolas Bougas, et al.Pediatric Blood & Cancer|January 11, 2013
Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcomaVéronique Minard-Colin, Frédéric Kolb, Christian Saint-Rose, et al.Pediatric Blood & Cancer|October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohortMartin Benesch, Karolina Nemes, Petra Neumayer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade GliomaJacques Grill, Maura Massimino, Eric Bouffet, et al.Plos One|June 16, 2017
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratificationFelipe Andreiuolo, Gwénaël Le Teuff, Mohamed Amine Bayar, et al.International Journal of Radiation Oncology, Biology, Physics|June 2, 2005
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocolChristian Carrie, Xavier Muracciole, Frédéric Gomez, et al.Lancet Regional Health. Americas|March 24, 2025
Epidemiology, incidence, and outcome of childhood cancers in the Afro-descendant population of the French West Indies and French Guiana: a population-based studyClaire Dichamp, Brigitte Lacour, Jacqueline Clavel, et al.British Journal of Cancer|August 21, 2023
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?Nicolas Bougas, Rodrigue S Allodji, Chiraz Fayech, et al.Acta Neuropathologica|December 8, 2023
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisationLucie Auffret, Yassine Ajlil, Arnault Tauziède-Espariat, et al.Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.Pageof 33